CADL Candel Therapeutics, Inc.: institutional ownership and insider trading
142 funds reported holding $530M of Candel Therapeutics, Inc. in their latest 13F filings; in Q2 2026 funds net bought $72.5M, with 39 new positions and 13 funds selling out; over the last 12 months insiders bought $3.00M and sold $3.55M on the open market.
Famous investors holding CADL
- Izzy Englander (Millennium Management): $11.3M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $2.59M, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $1.12M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $337K, 0.0% of the portfolio
Largest institutional holders of CADL
- FMR LLC — $113M
- RTW INVESTMENTS, LP — $66.1M
- BlackRock, Inc. (BLK) — $51.2M
- STATE STREET CORP (STT, STT-PG) — $36.6M
- ACORN CAPITAL ADVISORS, LLC — $36.0M
- Portolan Capital Management, LLC — $36.0M
- Saturn V Capital Management LP — $34.0M
- VANGUARD CAPITAL MANAGEMENT LLC — $27.7M
- GEODE CAPITAL MANAGEMENT, LLC — $16.2M
- VANGUARD GROUP INC — $13.0M
Recent CADL insider trades
- Sep 11, 2026: Tak Paul Peter sold 280,245 shares ($3.16M)
- Aug 17, 2026: Tyagarajan Seshu sold 7,000 shares ($84.0K)
- Jun 29, 2026: Barone Francesca sold 23,447 shares ($236K)
- Jun 29, 2026: Tyagarajan Seshu sold 7,000 shares ($70.1K)
5%+ owners
- RTW Investments, LP: 8.8% (Schedule 13G, filed May 15, 2026)
- Paul B Manning: 7.9% (Schedule 13D/A, filed Mar 18, 2026)
- BlackRock, Inc.: 6.6% (Schedule 13G, filed Jul 27, 2026)